126 related articles for article (PubMed ID: 30559916)
1. Opioid prescribing and dispensing: Experiences and perspectives from a survey of community pharmacists practising in the province of Quebec.
Dubé PA; Vachon J; Sirois C; Roy É
Can Pharm J (Ott); 2018; 151(6):408-418. PubMed ID: 30559916
[TBL] [Abstract][Full Text] [Related]
2. Pharmacists' experiences with dispensing opioids: provincial survey.
Kahan M; Wilson L; Wenghofer EF; Srivastava A; Resnick A; Janecek E; Sheehan C
Can Fam Physician; 2011 Nov; 57(11):e448-54. PubMed ID: 22084475
[TBL] [Abstract][Full Text] [Related]
3. Theoretical exploration of Tennessee community pharmacists' perceptions regarding opioid pain reliever abuse communication.
Hagemeier NE; Murawski MM; Lopez NC; Alamian A; Pack RP
Res Social Adm Pharm; 2014; 10(3):562-75. PubMed ID: 23981913
[TBL] [Abstract][Full Text] [Related]
4. Analysis of community chain pharmacists' interventions on electronic prescriptions.
Warholak TL; Rupp MT
J Am Pharm Assoc (2003); 2009; 49(1):59-64. PubMed ID: 19196598
[TBL] [Abstract][Full Text] [Related]
5. Community Pharmacists' Perspectives on Dispensing Medications With the Potential for Misuse, Diversion, and Intentional Overdose: Results of a Province-Wide Survey of Community Pharmacists in Canada.
Leong C; Alessi-Severini S; Sareen J; Enns MW; Bolton J
Subst Use Misuse; 2016 Nov; 51(13):1724-30. PubMed ID: 27487323
[TBL] [Abstract][Full Text] [Related]
6. Pharmacists' training, perceived roles, and actions associated with dispensing controlled substance prescriptions.
Fleming ML; Barner JC; Brown CM; Shepherd MD; Strassels SA; Novak S
J Am Pharm Assoc (2003); 2014; 54(3):241-50. PubMed ID: 24816350
[TBL] [Abstract][Full Text] [Related]
7. Impact of the RESPOND Toolkit on community pharmacists' opioid safety attitudes, self-efficacy, and knowledge.
Irwin AN; Novak K; Alley L; Havlin T; O'Kane N; Johnston K; Hildebran C; Carson J; Hartung DM
J Am Pharm Assoc (2003); 2020; 60(3):450-455.e3. PubMed ID: 31919007
[TBL] [Abstract][Full Text] [Related]
8. Challenges faced with opioid prescriptions in the community setting - Australian pharmacists' perspectives.
Makdessi CJ; Day C; Chaar BB
Res Social Adm Pharm; 2019 Aug; 15(8):966-973. PubMed ID: 30819418
[TBL] [Abstract][Full Text] [Related]
9. Preparing pharmacists to increase naloxone dispensing within community pharmacies under the Pennsylvania standing order.
Santa HM; Amirova SG; Ventricelli DJ; Downs GE; Nowalk AA; Pringle JL; Aruru M
Am J Health Syst Pharm; 2021 Feb; 78(4):327-335. PubMed ID: 33336254
[TBL] [Abstract][Full Text] [Related]
10. Prescribing and dispensing for drug misusers in primary care: current practice in Scotland.
Matheson C; Bond CM; Hickey F
Fam Pract; 1999 Aug; 16(4):375-9. PubMed ID: 10493708
[TBL] [Abstract][Full Text] [Related]
11. Challenges to the implementation of a nationwide electronic prescribing network in primary care: a qualitative study of users' perceptions.
Motulsky A; Sicotte C; Gagnon MP; Payne-Gagnon J; Langué-Dubé JA; Rochefort CM; Tamblyn R
J Am Med Inform Assoc; 2015 Jul; 22(4):838-48. PubMed ID: 25882033
[TBL] [Abstract][Full Text] [Related]
12. Pharmacists' knowledge of and attitudes toward opioid pain medications in relation to federal and state policies.
Joranson DE; Gilson AM
J Am Pharm Assoc (Wash); 2001; 41(2):213-20. PubMed ID: 11297334
[TBL] [Abstract][Full Text] [Related]
13. Survey of Ontario primary care physicians' experiences with opioid prescribing.
Wenghofer EF; Wilson L; Kahan M; Sheehan C; Srivastava A; Rubin A; Brathwaite J
Can Fam Physician; 2011 Mar; 57(3):324-32. PubMed ID: 21402971
[TBL] [Abstract][Full Text] [Related]
14. The role of pharmacies and pharmacists in managing controlled substance dispensing.
Hoppe J; Howland MA; Nelson L
Pain Med; 2014 Dec; 15(12):1996-8. PubMed ID: 25138390
[TBL] [Abstract][Full Text] [Related]
15. Applying the capability, opportunity, motivation, and behavior model to identify opportunities to increase pharmacist comfort dispensing naloxone in Texas: A structural equation modeling approach.
Varisco TJ; Downs CG; Rathburn KR; Fleming ML; Thornton JD
Int J Drug Policy; 2020 Sep; 83():102827. PubMed ID: 32589581
[TBL] [Abstract][Full Text] [Related]
16. [Opioid agonist therapy and the German Narcotic Drugs Prescription Ordinance from the pharmacist's perspective].
Kuhn S; Lehmann K; Schulte B; Verthein U
Z Evid Fortbild Qual Gesundhwes; 2022 Feb; 168():57-64. PubMed ID: 34955439
[TBL] [Abstract][Full Text] [Related]
17. Kentucky pharmacists' experiences in dispensing abuse-deterrent opioid analgesics.
Oyler DR; Slavova S; Brown JR; Dasgupta N; Freeman PR
J Am Pharm Assoc (2003); 2022; 62(6):1836-1842. PubMed ID: 36031547
[TBL] [Abstract][Full Text] [Related]
18. Medication Risk Management in Routine Dispensing in Community Pharmacies.
Kallio S; Eskola T; Pohjanoksa-Mäntylä M; Airaksinen M
Int J Environ Res Public Health; 2020 Nov; 17(21):. PubMed ID: 33167543
[TBL] [Abstract][Full Text] [Related]
19. Naloxone for opioid overdose prevention: pharmacists' role in community-based practice settings.
Bailey AM; Wermeling DP
Ann Pharmacother; 2014 May; 48(5):601-6. PubMed ID: 24523396
[TBL] [Abstract][Full Text] [Related]
20. The impact of electronic prescribing on the professionalization of community pharmacists: a qualitative study of pharmacists' perception.
Motulsky A; Winslade N; Tamblyn R; Sicotte C
J Pharm Pharm Sci; 2008; 11(1):131-46. PubMed ID: 18445369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
